Skip to main content
NVDA+1.03%AAPL-0.05%GOOGL+0.86%MSFT+0.98%AMZN+0.85%TSM+2.75%SPCX+7.63%META+0.25%AVGO+2.08%TSLA+0.81%SKHY-0.06%MU+0.24%BRK-B+0.32%LLY+0.02%AMD-0.34%JPM0.00%WMT+0.78%ASMLa+0.45%V+2.51%XOM+0.01%JNJ-1.21%INTC-2.63%0700.HK+1.23%MA+2.23%ABBV+1.12%1398.HK+1.61%CSCO+0.55%LRCX-0.49%AP2d+1.03%AMAT+0.41%CVX-0.11%ORCL+0.18%COST+0.31%CAT+0.32%BAC+0.47%KO+1.00%DELL-1.86%PG+0.71%UNH+1.80%0005.HK+1.93%HSBA.L+0.81%3988.HK+1.69%ARM-1.49%1816.HK+0.48%GE-1.04%0857.HK+1.04%MS-0.06%0939.HK+1.47%PM+1.10%1288.HK+0.92%PLNJPY+0.86%USDZAR-0.75%AUDCHF+0.72%USDMXN-0.71%USDPLN-0.70%AUDJPY+0.61%CHFSEK-0.57%GBPCHF+0.54%USDSEK-0.54%GBPJPY+0.46%NZDMXN-0.43%NOKJPY+0.42%GBPTRY+0.41%EURZAR-0.39%EURHKD+0.38%USDDKK-0.36%AUDUSD+0.36%EURCHF+0.35%AUDCAD+0.35%GBPZAR-0.35%AUDNZD+0.33%EURPLN-0.33%EURCNH+0.33%GBPHKD+0.32%NZDCHF+0.30%CHFNOK-0.29%SGDJPY+0.29%GBPMXN-0.28%USDCHF+0.28%GBPCAD+0.27%CADCHF+0.27%EURAUD-0.27%USDNOK-0.27%GBPUSD+0.27%EURJPY+0.26%GBPSGD+0.26%GBPNZD+0.25%AUDDKK-0.23%EURSGD+0.23%NZDJPY+0.23%USDJPY+0.21%CADJPY+0.19%EURCZK-0.19%EURGBP-0.18%CHFSGD-0.17%EURSEK-0.17%USDILS+0.16%NZDSGD+0.15%USDTHB+0.15%AUDNOK-0.15%USDSGD-0.14%GBPAUD-0.13%EURNOK+0.11%USDTRY+0.11%CHFJPY-0.09%EURCAD+0.08%EURUSD+0.08%EURNZD+0.07%USDCOP-0.04%USDCNH-0.04%NZDCAD+0.03%NZDUSD+0.02%AUDSGD-0.02%EURDKK+0.01%USDCAD+0.01%USDHKD+0.01%UKOIL-2.77%COCOA-2.42%USOIL-2.04%XPTUSD-1.15%W1+0.96%C1+0.85%GAUUSD+0.83%XAUUSD+0.83%XNGUSD+0.72%S1+0.63%GAGUSD+0.45%XAGUSD+0.45%BTCUSD+0.55%ETHUSD+6.15%USDTUSD-0.03%XRPUSD-0.54%SOLUSD-2.00%TRXUSDT-0.21%ZECUSDT+2.40%DOGEUSD-1.82%XMRUSDT-0.32%LINKUSD+3.21%XLMUSD+0.19%BCHUSDT0.00%UNIUSD-2.06%LTCUSD-4.60%SUIUSD-1.21%HBARUSDT-0.98%TONUSD+12.52%TAOUSDT-0.66%AAVEUSD-0.01%DOTUSDT-0.86%ICPUSDT-4.20%ONDOUSDT-0.46%WLDUSDT+1.36%ARBUSDT-3.27%JUPUSDT-1.29%ATOMUSDT-0.80%INJUSDT+1.56%STXUSDT-0.18%FETUSDT-1.82%SEIUSDT-0.61%PYTHUSDT+0.98%TIAUSDT-0.59%IMXUSDT-2.28%GRTUSDT-0.89%OPUSDT-2.99%IOTAUSDT+3.59%WIFUSDT0.00%AXSUSDT-1.48%POLUSDT-0.34%FARTCOINUSDT+1.81%EOSUSDT+5.02%DYDXUSDT-2.45%GALAUSDT-0.92%ORDIUSDT+1.87%RONINUSDT+3.69%NOTUSDT+1.29%NVDA+1.03%AAPL-0.05%GOOGL+0.86%MSFT+0.98%AMZN+0.85%TSM+2.75%SPCX+7.63%META+0.25%AVGO+2.08%TSLA+0.81%SKHY-0.06%MU+0.24%BRK-B+0.32%LLY+0.02%AMD-0.34%JPM0.00%WMT+0.78%ASMLa+0.45%V+2.51%XOM+0.01%JNJ-1.21%INTC-2.63%0700.HK+1.23%MA+2.23%ABBV+1.12%1398.HK+1.61%CSCO+0.55%LRCX-0.49%AP2d+1.03%AMAT+0.41%CVX-0.11%ORCL+0.18%COST+0.31%CAT+0.32%BAC+0.47%KO+1.00%DELL-1.86%PG+0.71%UNH+1.80%0005.HK+1.93%HSBA.L+0.81%3988.HK+1.69%ARM-1.49%1816.HK+0.48%GE-1.04%0857.HK+1.04%MS-0.06%0939.HK+1.47%PM+1.10%1288.HK+0.92%PLNJPY+0.86%USDZAR-0.75%AUDCHF+0.72%USDMXN-0.71%USDPLN-0.70%AUDJPY+0.61%CHFSEK-0.57%GBPCHF+0.54%USDSEK-0.54%GBPJPY+0.46%NZDMXN-0.43%NOKJPY+0.42%GBPTRY+0.41%EURZAR-0.39%EURHKD+0.38%USDDKK-0.36%AUDUSD+0.36%EURCHF+0.35%AUDCAD+0.35%GBPZAR-0.35%AUDNZD+0.33%EURPLN-0.33%EURCNH+0.33%GBPHKD+0.32%NZDCHF+0.30%CHFNOK-0.29%SGDJPY+0.29%GBPMXN-0.28%USDCHF+0.28%GBPCAD+0.27%CADCHF+0.27%EURAUD-0.27%USDNOK-0.27%GBPUSD+0.27%EURJPY+0.26%GBPSGD+0.26%GBPNZD+0.25%AUDDKK-0.23%EURSGD+0.23%NZDJPY+0.23%USDJPY+0.21%CADJPY+0.19%EURCZK-0.19%EURGBP-0.18%CHFSGD-0.17%EURSEK-0.17%USDILS+0.16%NZDSGD+0.15%USDTHB+0.15%AUDNOK-0.15%USDSGD-0.14%GBPAUD-0.13%EURNOK+0.11%USDTRY+0.11%CHFJPY-0.09%EURCAD+0.08%EURUSD+0.08%EURNZD+0.07%USDCOP-0.04%USDCNH-0.04%NZDCAD+0.03%NZDUSD+0.02%AUDSGD-0.02%EURDKK+0.01%USDCAD+0.01%USDHKD+0.01%UKOIL-2.77%COCOA-2.42%USOIL-2.04%XPTUSD-1.15%W1+0.96%C1+0.85%GAUUSD+0.83%XAUUSD+0.83%XNGUSD+0.72%S1+0.63%GAGUSD+0.45%XAGUSD+0.45%BTCUSD+0.55%ETHUSD+6.15%USDTUSD-0.03%XRPUSD-0.54%SOLUSD-2.00%TRXUSDT-0.21%ZECUSDT+2.40%DOGEUSD-1.82%XMRUSDT-0.32%LINKUSD+3.21%XLMUSD+0.19%BCHUSDT0.00%UNIUSD-2.06%LTCUSD-4.60%SUIUSD-1.21%HBARUSDT-0.98%TONUSD+12.52%TAOUSDT-0.66%AAVEUSD-0.01%DOTUSDT-0.86%ICPUSDT-4.20%ONDOUSDT-0.46%WLDUSDT+1.36%ARBUSDT-3.27%JUPUSDT-1.29%ATOMUSDT-0.80%INJUSDT+1.56%STXUSDT-0.18%FETUSDT-1.82%SEIUSDT-0.61%PYTHUSDT+0.98%TIAUSDT-0.59%IMXUSDT-2.28%GRTUSDT-0.89%OPUSDT-2.99%IOTAUSDT+3.59%WIFUSDT0.00%AXSUSDT-1.48%POLUSDT-0.34%FARTCOINUSDT+1.81%EOSUSDT+5.02%DYDXUSDT-2.45%GALAUSDT-0.92%ORDIUSDT+1.87%RONINUSDT+3.69%NOTUSDT+1.29%
EN

Enovis Corporation (ENOV)

NYSE • Healthcare

$18.69
+$0.92 (+5.2%)
Market closed

Last close at October 5, 2026 at 20:00 UTC

Open$17.7
Day Range$17.56 - $18.96
Avg. Volume (3M)2M
Market Cap$1B
52 Week Range
$17.3$34.28
Next EarningsIn 30 daysNov 5, 2026

Metrics Over Time

Where the Money Goes

Q3 2026
Revenueeverything earned$582.7M100%
Gross Profitminus cost of goods$359.2M62%
Operating Incomeminus R&D and overhead$17.4M3%

Fundamentals & Financials

Revenue (TTM)
$2.2B
Net Income (TTM)
-$1.1B
EPS (TTM)
-$19.4
ROA (TTM)
-29.25%
Current Ratio
1.98
Dividend Yield
0%

TTM is calculated as the sum of the four most recently completed quarters. This is a standard approach when monthly or real-time data is not available.

Earnings

+17.3%Q1 2026$0.95
+8.5%Q2 2026$0.89
+6.3%Q3 2026$0.9
Next

Nov 5

in 30 daysQ4 2026

% — EPS deviation from the forecast (beat / miss); quarters without a forecast show the reported EPS

Latest report — Q3 2026
Beat +6.3%

Enovis Corporation beat consensus on both the top and bottom line in the second fiscal quarter of 2026, reported August 6 based on preliminary results, as adjusted EPS of $0.90 topped the $0.85 estimate by 6.3% and revenue of about $582.8 million edged the $581.8 million consensus by 0.2%. Revenue rose about 3% from about $564.5 million a year ago, while gross margin held near 62% and operating margin was about 3% as operating income came in around $17.4 million. Adjusted EPS was up about 14% from $0.79 a year ago, and the company generated operating cash flow of $75.0 million. Consensus for the next period calls for adjusted EPS of $0.85 on revenue of $562.1 million.

Next report — what to expect

Enovis Corporation (ENOV) reports on November 5, 2026. Wall Street is looking for consensus EPS of $0.76 on revenue of $557.1 million. For trailing context, revenue rose +3.2% year over year last quarter. ENOV has beaten EPS in 8 of its 8 most recent quarters.

View full earnings history

About Enovis Corporation

Enovis Corporation is a medical device company listed on the NYSE as ENOV that develops and sells orthopedic, rehabilitation, and reconstructive products worldwide. Under the DJO brand, it generated $2.2 billion of revenue in FY2025 from a portfolio that spans bracing, therapy, and implantable joint-reconstruction products.

Name
Enovis Corporation
CEO
Damien McDonald
Website
www.enovis.com
Industry
Healthcare
Employees
7,802

Today's Snapshot

AI-generated

ENOV ended yesterday 5.2% up at 18.69.

Trading Volume

Below 10d avg (1.5M)

1.3M

vs S&P 500 Today

Strong Outperformance

+4.52%

Updated: October 6, 2026 at 12:23 UTC

Technical Indicators

1 Buy3 Neutral4 Sell
ENOV trades above its pivot but the technical picture favors selling because the stock remains beneath long-term averages and lacks convincing trend strength: ADX is modest in the low 20s. Momentum indicators are mixed to neutral, with RSI and MACD near flat while short-term moving averages show some support under price; however the 200-day averages are well above, marking longer-term resistance. Volatility is elevated with ATR near 5.5% and OBV is strongly negative, suggesting distribution despite occasional short-term support at the pivot. Technical takeaway: overall sell bias due to weak trend and poor volume backdrop.
All signals
  • EMA (5 indicators)$18.34 - $24.27
    Sell
  • RSI (14)42.91
    Neutral
  • Stochastic %K (14, 3, 3)41.17
    Neutral
  • MACD Level (12, 26)-1.15
    Neutral

Peers & Related Assets

ITTITT Inc.
$206.2+0.0%
IEXIDEX Corporation
$235.29+1.0%
WTSWatts Water Technologies, Inc.
$362.75-0.1%
DCIDonaldson Company, Inc.
$89.19+0.6%
NPOEnPro Industries, Inc.
$332.86+0.1%
FELEFranklin Electric Co., Inc.
$99.04+0.4%
Stay Ahead of the Market

Get premium market insights delivered directly to your inbox.